Transformation of myelodysplastic syndromes into acute myeloid leukemias
J Shi, Z Shao, H Liu, J Bai, Y Cao, G He, M Tu… - Chinese medical …, 2004 - mednexus.org
Background Myelodysplastic syndromes (MDSs), also called preleukemias, are a group of
myeloid hematopoietic malignant disorders. We studied the transformation of MDS into acute …
myeloid hematopoietic malignant disorders. We studied the transformation of MDS into acute …
The role of cytokines in lymphoma with anemia
T Wang, MF Tu, J Zhu, W Zheng… - … Shi Yan Xue Ye Xue Za …, 2013 - europepmc.org
This study was purposed to investigate the role of cytokines in pathogenesis of lymphoma-associated
anemia. The levels of IFN-γ, IL-1β, IL-6, TNF-α and EPO in serum from 45 …
anemia. The levels of IFN-γ, IL-1β, IL-6, TNF-α and EPO in serum from 45 …
[HTML][HTML] Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma
WP Liu, XP Wang, W Zheng, Y Xie, MF Tu, NJ Lin… - Annals of …, 2018 - Springer
Interstitial pneumonia (IP) is a lethal complication in lymphoma patients undergoing
chemotherapy. A total of 2212 consecutive patients diagnosed with lymphoma between 2009 and …
chemotherapy. A total of 2212 consecutive patients diagnosed with lymphoma between 2009 and …
[HTML][HTML] The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma
ZT Ying, W Zheng, XP Wang, Y Xie, MF Tu… - Chinese Journal of …, 2012 - ncbi.nlm.nih.gov
Mantle cell lymphoma (MCL), a special type of non-Hodgkin's lymphoma, is incurable
through conventional treatment. This study aimed to analyze the clinical features, therapeutic …
through conventional treatment. This study aimed to analyze the clinical features, therapeutic …
Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection
…, L Sun, W Zheng, Y Xie, XP Wang, MF Tu… - … shi yan xue ye xue za …, 2014 - europepmc.org
This study was purposed to investigate the expression of latent membrane protein 1 (LMP-1)
and CD68 in Hodgkin's lymphoma (HL) patients with EB virus infection and to analyze the …
and CD68 in Hodgkin's lymphoma (HL) patients with EB virus infection and to analyze the …
[HTML][HTML] 415. first-in-patient proof of safety and efficacy of a 4th generation chimeric antigen receptor-modified T cells for the treatment of relapsed or refractory CD30 …
…, XP Wang, WP Liu, W Zheng, Y Xie, NJ Lin, MF Tu… - Molecular Therapy, 2015 - cell.com
Background Many lymphoma patients cannot be cured by standard chemo-radiotherapy.
CD30 is expressed in Hodgkin's lymphoma (HL), anaplastic large cell lymphoma (ALCL), …
CD30 is expressed in Hodgkin's lymphoma (HL), anaplastic large cell lymphoma (ALCL), …
An analysis of hepatitis B virus infection rate in 405 cases of non-Hodgkin lymphoma
…, XP Wang, YQ Song, Y Xie, MF Tu… - Zhonghua xue ye xue …, 2011 - europepmc.org
Objective To analyze the status of hepatitis B virus (HBV) infection in non-Hodgkin lymphoma
(NHL) patients. Methods The serum HBV markers in NHL patients were detected by …
(NHL) patients. Methods The serum HBV markers in NHL patients were detected by …
The clinical features of hepatitis associated aplastic anemia
MF Tu, ZH Shao, H Liu, GS He, J Bai, J Shi… - Zhonghua xue ye xue …, 2005 - europepmc.org
Objective To analyse the proportion of hepatitis associated aplastic anemia (HAAA) in severe
aplastic anemia (SAA) and its clinical features of HAAA. Methods All newly diagnosed SAA …
aplastic anemia (SAA) and its clinical features of HAAA. Methods All newly diagnosed SAA …
Study on the peripheral blood dendritic cells subtypes and the expression of co-stimulating molecules on dendritic cells and B cells in severe aplastic anemia patients
MF Tu, ZH Shao, H Liu, GS He, J Shi, J Bai… - Zhonghua xue ye xue …, 2006 - europepmc.org
Objective To investigate the quantities of monocyte-derived dendritic cell precursors (pDC1)
and plasmacytoid dendritic cell precursors (pDC2) in peripheral blood mononuclear cells (…
and plasmacytoid dendritic cell precursors (pDC2) in peripheral blood mononuclear cells (…
The quantity, subsets and expression of costimulatory molecules of circulating dendritic cells in the patients with myelodysplastic syndromes
HQ Wang, ZH Shao, LM Xing, R Fu, MF Tu… - Zhonghua xue ye xue …, 2007 - europepmc.org
Objective To investigate the quantity, subset of dendritic cells (DC) and their costimulatory
molecule expression in peripheral blood (PB) of the patients with myelodysplastic syndromes (…
molecule expression in peripheral blood (PB) of the patients with myelodysplastic syndromes (…